Cigna Investments’s Travelers Companies TRV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $659K | Sell |
1,996
-129
| -6% | -$39.1K | 0.09% | 205 |
|
|
2026
Q1 | $620K | Sell |
2,125
-36
| -2% | -$10.5K | 0.1% | 198 |
|
|
2025
Q4 | $627K | Sell |
2,161
-61
| -3% | -$17.2K | 0.09% | 191 |
|
|
2025
Q3 | $620K | Hold |
2,222
| – | – | 0.09% | 195 |
|
|
2025
Q2 | $594K | Sell |
2,222
-41
| -2% | -$10.8K | 0.1% | 199 |
|
|
2025
Q1 | $598K | Sell |
2,263
-52
| -2% | -$13K | 0.11% | 188 |
|
|
2024
Q4 | $558K | Sell |
2,315
-20
| -0.9% | -$4.99K | 0.1% | 203 |
|
|
2024
Q3 | $546K | Sell |
2,335
-52
| -2% | -$11.5K | 0.1% | 205 |
|
|
2024
Q2 | $485K | Sell |
2,387
-22
| -0.9% | -$4.73K | 0.09% | 214 |
|
|
2024
Q1 | $554K | Sell |
2,409
-26
| -1% | -$5.55K | 0.1% | 194 |
|
|
2023
Q4 | $464K | Hold |
2,435
| – | – | 0.1% | 216 |
|
|
2023
Q3 | $398K | Sell |
2,435
-402
| -14% | -$67.1K | 0.09% | 232 |
|
|
2023
Q2 | $492K | Sell |
2,837
-22
| -0.8% | -$3.88K | 0.09% | 222 |
|
|
2023
Q1 | $490K | Sell |
2,859
-62
| -2% | -$11.3K | 0.1% | 216 |
|
|
2022
Q4 | $547K | Sell |
2,921
-24
| -0.8% | -$4.32K | 0.11% | 190 |
|
|
2022
Q3 | $451K | Sell |
2,945
-163
| -5% | -$26.5K | 0.1% | 205 |
|
|
2022
Q2 | $526K | Sell |
3,108
-1,131
| -27% | -$197K | 0.1% | 198 |
|
|
2022
Q1 | $774K | Sell |
4,239
-1,329
| -24% | -$228K | 0.1% | 206 |
|
|
2021
Q4 | $870K | Sell |
5,568
-2,120
| -28% | -$331K | 0.07% | 237 |
|
|
2021
Q3 | $1.17M | Sell |
7,688
-147
| -2% | -$22.8K | 0.09% | 208 |
|
|
2021
Q2 | $1.17M | Sell |
7,835
-1,238
| -14% | -$192K | 0.08% | 211 |
|
|
2021
Q1 | $1.36M | Buy |
9,073
+264
| +3% | +$38.8K | 0.09% | 197 |
|
|
2020
Q4 | $1.24M | Buy |
8,809
+636
| +8% | +$81.7K | 0.1% | 186 |
|
|
2020
Q3 | $885K | Sell |
8,173
-50
| -0.6% | -$5.73K | 0.09% | 206 |
|
|
2020
Q2 | $937K | Buy |
8,223
+1,000
| +14% | +$105K | 0.09% | 211 |
|
|
2020
Q1 | $718K | Buy |
7,223
+450
| +7% | +$56K | 0.09% | 232 |
|
|
2019
Q4 | $892K | Sell |
6,773
-971
| -13% | -$132K | 0.09% | 263 |
|
|
2019
Q3 | $1.01M | Buy |
7,744
+350
| +5% | +$52K | 0.1% | 248 |
|
|
2019
Q2 | $1.08M | Sell |
7,394
-250
| -3% | -$36.1K | 0.12% | 228 |
|
|
2019
Q1 | $1.05M | Sell |
7,644
-200
| -3% | -$25.6K | 0.12% | 222 |
|
|
2018
Q4 | $938K | Sell |
7,844
-84
| -1% | -$10.5K | 0.08% | 184 |
|
|
2018
Q3 | $992K | Sell |
7,928
-665
| -8% | -$85.8K | 0.08% | 189 |
|
|
2018
Q2 | $1.05M | Sell |
8,593
-1,400
| -14% | -$183K | 0.08% | 239 |
|
|
2018
Q1 | $1.39M | Sell |
9,993
-211
| -2% | -$29.5K | 0.09% | 179 |
|
|
2017
Q4 | $1.39M | Sell |
10,204
-447
| -4% | -$59K | 0.09% | 170 |
|
|
2017
Q3 | $1.3M | Sell |
10,651
-84
| -0.8% | -$10.5K | 0.09% | 183 |
|
|
2017
Q2 | $1.36M | Buy |
+10,735
| New | +$1.32M | 0.09% | 176 |
|
|
2017
Q1 | – | Sell |
-10,602
| Closed | -$1.3M | – | 769 |
|
|
2016
Q4 | $1.3M | Buy |
+10,602
| New | +$1.21M | 0.14% | 174 |
|
Other funds holding TRV
SMDAM
VF
AT
SGK
QCM
CFB
Cigna Investments's TRV Position: Q2 2026 in Review
Cigna Investments reduced its Travelers Companies (TRV) stake by 6.1% in Q2 2026, selling an estimated $39.1K and leaving 1,996 shares worth $659K. The position accounts for 0.09% of the portfolio, ranked #205.
Cigna Investments first reported a position in TRV in Q4 2016 and has held it in 38 quarters since. The position peaked at $1.39M in Q1 2018. 632 funds tracked by Wall St. Rank hold TRV as of Q2 2026.
- Cigna Investments held 1,996 shares of Travelers Companies worth $659K as of Q2 2026.
- Cigna Investments sold 129 Travelers Companies shares in Q2 2026, an estimated $39.1K.
- Travelers Companies made up 0.09% of Cigna Investments's portfolio in Q2 2026, its #205 holding.
- Cigna Investments first reported a position in Travelers Companies in Q4 2016 and has held it in 38 quarters since.
- Cigna Investments's Travelers Companies position peaked at $1.39M in Q1 2018.
- 632 funds tracked by Wall St. Rank held Travelers Companies as of Q2 2026.
Based on Cigna Investments's 13F filing for Q2 2026, filed 21 Jul 2026.